Evidence map›Paper›PMID 39141824›Full record

ArticleMolecular pharmaceutics2024

Unraveling the Potential of Vitamin B

Adriana Olejniczak, Witold Stachowiak, Daniel Ziental, Jolanta Długaszewska, Tomasz Rzemieniecki, Marcin Wysokowski, Teofil Jesionowski, Michał Niemczak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adriana OlejniczakFaculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.ORCID 0000-0002-3053-0171
Witold StachowiakFaculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.ORCID 0000-0002-6484-4507
Daniel ZientalChair and Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland.ORCID 0000-0002-4923-9982
Jolanta DługaszewskaChair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland.
Tomasz RzemienieckiFaculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.ORCID 0000-0002-9146-0082
Marcin WysokowskiFaculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.ORCID 0000-0003-0624-2716
Teofil JesionowskiFaculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.ORCID 0000-0002-7808-8060
Michał NiemczakFaculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.ORCID 0000-0002-4364-8267

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study is focused on the utilization of naturally occurring salicylic acid and nicotinamide (vitamin B

Indexed as

Acne VulgarisAnti-Bacterial AgentsMolecular Docking SimulationNiacinamideAnionsAnti-Inflammatory AgentsHumansMicrobial Sensitivity TestsPropionibacteriaceaeSalicylatesSalicylic AcidSaltsSolubilityAnionsAnti-Bacterial AgentsAnti-Inflammatory AgentsNiacinamideSalicylatesSalicylic AcidSaltsacne vulgarisactive pharmaceutical ingredientsantimicrobial activityAPInicotinamidesalicylic acid

Identifiers

PMID39141824
PMCPMC11372839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.